Skip to content

A f-MRI Study Of Affective Changes Associated With Four Weeks Consumption Of A Fermented Dairy Product In Healthy Women

A f-MRI STUDY OF AFFECTIVE CHANGES ASSOCIATED WITH FOUR WEEKS CONSUMPTION OF A FERMENTED DAIRY PRODUCT IN HEALTHY WOMEN

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01398163
Enrollment
51
Registered
2011-07-20
Start date
2009-04-30
Completion date
2010-12-31
Last updated
2016-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult Women

Keywords

probiotics, digestive well-being, fMRI, brain-gut axis

Brief summary

The purpose of this study is to evaluate the effect of a commercially available fermented dairy product containing probiotics (4 weeks, twice a day) on the brain activity within specific neural circuits regulating the subjective experience of emotional valence and digestive well-being.

Interventions

Arm 1 - Intervention 1 (probiotics)

Arm 2 - Intervention 2 (control)

Sponsors

Danone Global Research & Innovation Center
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy women, right-handed, aged from 18 to 60 years * Subject of normal body weight or with overweight i.e. not obese (body mass index between 18 and 30 kg/m2). * For fertile women, complying with one of the other medically approved methods of contraception

Exclusion criteria

* Subject with any current psychiatric or eating or suicidal attempt disorder, or history of such disorder. * Subject with any history of chronic GI disorder or disease. * Subject with any significant active or prior metabolic disorder or disease. * Subject with any use of probiotic supplements or antibiotics in the previous month. * Subject with current use of any medications with potential central nervous system effects (antidepressants, anxiolytics, opiate pain medications...). * Subject with allergy or hypersensitivity to milk proteins or lactose intolerance or immunodeficiency * Subjects with claustrophobia or other condition (such as metallic implants) that would preclude MRI scanning

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026